LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE)

BACKGROUND: SAB is common, serious, and potentially lethal. Antibiotic options are limited, especially for MRSA. Ceftobiprole is an advanced-generation cephalosporin with bactericidal activity against Gram-positive (including MRSA) and Gram-negative pathogens, with efficacy and safety demonstrated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, Thomas L, Cosgrove, Sara E, Doernberg, Sarah B, Pavlov, Oleksander, Titov, Ivan, Atanasov, Boyko, Gehr, Maziar Assadi, Engelhardt, Marc, Hamed, Kamal, Ionescu, Daniel, Jones, Mark, Sauley, Mikael, Smart, Jennifer, Seifert, Harald, Jenkins, Timothy C, Turner, Nicholas A, Fowler, Vance G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752497/
http://dx.doi.org/10.1093/ofid/ofac492.1892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752497/
http://dx.doi.org/10.1093/ofid/ofac492.1892

Ejemplares similares